EAM
ANAB icon

Erste Asset Management’s AnaptysBio ANAB Stock Holding History

Erste Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,500
Closed -$409K – 406
2019
Q2 		$409K Hold
7,500
– – 0.02% 330
2019
Q1 		$518K Hold
7,500
– – 0.03% 314
2018
Q4 		$463K Buy
+7,500
New +$558K 0.03% 315

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Erste Asset Management's ANAB Position: Q3 2019 in Review

Erste Asset Management sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 7,500 shares — an estimated $409K sold.

Erste Asset Management first reported a position in ANAB in Q4 2018 and held it in 3 quarters. The position peaked at $518K in Q1 2019. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • Erste Asset Management reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • Erste Asset Management sold 7,500 AnaptysBio shares in Q3 2019, an estimated $409K.
  • Erste Asset Management first reported a position in AnaptysBio in Q4 2018 and held it in 3 quarters.
  • Erste Asset Management's AnaptysBio position peaked at $518K in Q1 2019.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Erste Asset Management's 13F filing for Q3 2019, filed 22 Nov 2024.